Wings for Life UK Spinal Cord Research Foundation

Wings for Life UK Spinal Cord Research Foundation, established in 2010 as the UK branch of the global Wings for Life organization, is a registered UK charity dedicated to funding high-quality scientific and medical research aimed at curing spinal cord injuries (SCI). Its mission centers on advancing understanding, diagnosis, prevention, and treatment of SCI through evidence-based, patient-focused investments that foster neuroregeneration, novel therapies, rehabilitation, and clinical breakthroughs. Core values emphasize scientific excellence, international collaboration, and real-world impact, with UK-raised funds prioritized for UK-based projects while supporting global advancements.

The foundation funds basic biomedical research, translational studies, clinical trials, researcher training, and networks exclusively targeting SCI mechanisms, recovery processes, and quality-of-life improvements for people with spinal cord injuries, disability communities, and the public. Grant types include project grants, individual support for PhD students, postdocs, and technicians, and the Accelerated Translational Programme for major clinical trials.

Eligible applicants are UK-registered charities and academic institutions (including universities and NHS Trusts) with proven SCI expertise and facilities; no income thresholds apply, and while worldwide applications are accepted, UK researchers receive priority. The two-stage process requires an online preliminary application (EOI) by 1 September annually, with ~30-40% invited to full proposals by 2 November; decisions follow peer review by March. Typical project grants reach €130,000 (£110,000) per year for up to three years (max. €390,000/£330,000); individual grants range €21,000-€57,000 (£18,000-£49,000) yearly; clinical trials may exceed US$3 million.

Exclusions cover non-SCI activities, core costs, or unrelated projects, ensuring laser-focused, high-impact funding. Wings for Life UK stands out for its unwavering SCI exclusivity, rigorous global process, and track record of transformative UK research toward a cure.